SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.08.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 21.08.14 | Roche buy | Deutsche Bank AG | |
| 21.08.14 | Novartis Hold | Deutsche Bank AG | |
| 19.08.14 | Novartis buy | UBS AG | |
| 19.08.14 | Roche overweight | JP Morgan Chase & Co. | |
| 18.08.14 | Roche buy | UBS AG | |
| 05.08.14 | Roche buy | UBS AG | |
| 05.08.14 | Novartis Hold | Deutsche Bank AG | |
| 29.07.14 | Roche buy | Citigroup Corp. | |
| 29.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 25.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 25.07.14 | Roche overweight | Morgan Stanley | |
| 25.07.14 | Roche Outperform | Bernstein Research | |
| 25.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 25.07.14 | Roche overweight | Barclays Capital | |
| 21.07.14 | Novartis Underweight | Morgan Stanley | |
| 21.07.14 | Novartis Equal weight | Barclays Capital | |
| 21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.07.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 17.07.14 | Roche buy | UBS AG | |
| 17.07.14 | Roche overweight | Morgan Stanley | |
| 17.07.14 | Novartis buy | S&P Capital IQ | |
| 15.07.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.07.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.14 | Novartis buy | UBS AG | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 14.07.14 | Novartis buy | Jefferies & Company Inc. | |
| 09.07.14 | Roche kaufen | Independent Research GmbH | |
| 07.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 02.07.14 | Novartis Hold | Deutsche Bank AG | |
| 02.07.14 | Novartis buy | UBS AG | |
| 02.07.14 | Roche buy | UBS AG | |
| 01.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 30.06.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 23.06.14 | Roche Hold | S&P Capital IQ | |
| 20.06.14 | Novartis Underweight | Morgan Stanley | |
| 19.06.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.06.14 | Novartis overweight | JP Morgan Chase & Co. |